European Health Technology Assessment
Ecker, Thomas; Kandola, Suki; Ritz-Jansen, Katja; Brozek, Antonia; Ahrens, Lucas; Marx, Elisabeth
"Implications of EU-HTA on Future Relevance of Real-World Data in National Assessments"
Poster presentation at ISPOR Boston, May 2023
Ahrens, Lucas; Marx, Elisabeth; Stengel, Stephanie; Ecker, Thomas
"EU-HTA in 2025: Industry's Stake in the Scoping Process"
Poster presentation at ISPOR Boston, May 2023
Ecker, Thomas; Kandola, Suki; Musiolik, Katharina; Ritz-Jansen, Katja; Brozek, Antonia; Ahrens, Lucas; Marx, Elisabeth
"Implications of EU-HTA on Acceptance of Indirect Treatment Comparisons in National Assessments"
Poster presentation at ISPOR Boston, May 2023
Ecker + Ecker comments on the current EUnetHTA 21 guideline Interaction between Health Technology Developer and HTA bodies (D7.1.1).
August 2022
Ecker + Ecker comments on the current EUnetHTA 21 guidelines Applicability of Evidence (D4.5), Validity of Clinical Studies (D4.6) and Guidance for JCA Submission Dossier Template (D5.1)
August 2022
Ecker + Ecker comments on the current EUnetHTA 21 scoping process guideline (D4.2).
May 2022
Ecker + Ecker comments on the current EUnetHTA 21 methodological guideline on direct and indirect comparisons (D4.3.2).
May 2022
Ecker + Ecker comments on the current EUnetHTA guideline on information retrieval.
September 2019
Ecker, Thomas; Baecke, Verena
"Mandatory Joint Clinical Assessment – What is the additional insight from EUnetHTA vs. EMA?"
Poster presentation at ISPOR Europe, November 2018
Please contact
Dr. Thomas Ecker
Phone +49 (40) 41 33 081-10